Acetaminophen and pregnancy: Short- and long-term consequences for mother and child

Journal of Reproductive Immunology

Volumn 97, Issue 1, 2013, Pages 128-139

  Thiele, Kristin ^a   Kessler, Timo ^a   Arck, Petra ^a   Erhardt, Annette ^a   Tiegs, Gisa ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Immune regulation; Inflammation; Mice; Reproduction

Indexed keywords

CODEINE; PARACETAMOL;

ADAPTATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMNION BAND SYNDROME; ARTICLE; ASTHMA; BLEEDING TIME; BRAIN HEMORRHAGE; CHILD HEALTH; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CRYPTORCHISM; DRUG EFFECT; DRUG METABOLISM; DRUG SAFETY; DRUG TRANSPORT; FETUS DEVELOPMENT; GASTROSCHISIS; GESTATIONAL AGE; HUMAN; IMMUNE SYSTEM; LIVER CELL; LIVER DISEASE; LIVER FUNCTION; LOW BIRTH WEIGHT; NEURAL TUBE DEFECT; NONHUMAN; ONTOGENY; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; WHEEZING;

ACETAMINOPHEN; ANTIPYRETICS; CHILD; FEMALE; FETAL DEVELOPMENT; FETUS; HUMANS; LIVER; MATERNAL EXPOSURE; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84874532166     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.10.014     Document Type: Article

References (115)

1. Abe K., Honein M.A., Moore C.A. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies. Birth Defects Res. A: Clin. Mol. Teratol. 2003, 67:911-918.
2. Achache H., Tsafrir A., Prus D., Reich R., Revel A. Defective endometrial prostaglandin synthesis identified in patients with repeated implantation failure undergoing in vitro fertilization. Fertil. Steril. 2010, 94:1271-1278.
3. Aleksunes L.M., Augustine L.M., Cherrington N.J., Manautou J.E. Influence of acetaminophen vehicle on regulation of transporter gene expression during hepatotoxicity. J. Toxicol. Environ. Health A 2007, 70:1870-1872.
4. Anderson B.J. Paracetamol (acetaminophen): mechanisms of action. Paediatr. Anaesth. 2008, 18:915-921.
5. Aselton P., Jick H., Milunsky A., Hunter J.R., Stergachis A. First-trimester drug use and congenital disorders. Obstet. Gynecol. 1985, 65:451-455.
6. + T cells. J. Immunol. 2005, 175:1483-1490.
7. Black R.A., Hill D.A. Over-the-counter medications in pregnancy. Am. Fam. Physician 2003, 67:2517-2524.
8. Bone-Larson C.L., Hogaboam C.M., Evanhoff H., Strieter R.M., Kunkel S.L. IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J. Immunol. 2001, 167:7077-7083.
9. Bone-Larson C.L., Simpson K.J., Colletti L.M., Lukacs N.W., Chen S.C., Lira S., Kunkel S.L., Hogaboam C.M. The role of chemokines in the immunopathology of the liver. Immunol. Rev. 2000, 177:8-20.
10. Boyson J.E., Nagarkatti N., Nizam L., Exley M.A., Strominger J.L. Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:4580-4585.
11. Burdan F. Developmental effects of propyphenazone in analgesic and antipyretic combination with caffeine or paracetamol. Hum. Exp. Toxicol. 2004, 23:235-244.
12. Burdan F., Siezieniewska Z., Kis G., Blicharski T. Embryofetotoxicity of acetaminophen (paracetamol) in experimental in vivo model. Ann. Univ. Mariae Curie Sklodowska Med. 2001, 56:89-94.
13. Byer A.J., Traylor T.R., Semmer J.R. Acetaminophen overdose in the third trimester of pregnancy. J. Am. Med. Assoc. 1982, 247:3114-3115.
14. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., Simmons D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13926-13931.
15. Cleves M.A., Savell V.H., Raj S., Zhao W., Correa A., Werler M.M., Hobbs C.A. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res. A: Clin. Mol. Teratol. 2004, 70:107-113.
16. Connolly M.K., Ayo D., Malhotra A., Hackman M., Bedrosian A.S., Ibrahim J., Cieza-Rubio N.E., Nguyen A.H., Henning J.R., Dorvil-Castro M., Pachter H.L., Miller G. Dendritic cell depletion exacerbates acetaminophen hepatotoxicity. Hepatology 2011, 54:959-968.
17. Cramer D.W., Liberman R.F., Hornstein M.D., Mcshane P., Powers D., Li E.Y., Barbieri R. Basal hormone levels in women who use acetaminophen for menstrual pain. Fertil. Steril. 1998, 70:371-373.
18. Crispe I.N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 2003, 3:51-62.
19. Czeizel A.E., Dudas I., Puho E. Short-term paracetamol therapy during pregnancy and a lower rate of preterm birth. Paediatr. Perinat. Epidemiol. 2005, 19:106-111.
20. Erhardt A., Biburger M., Papadopoulos T., Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007, 45:475-485.
21. Erhardt A., Wegscheid C., Claass B., Carambia A., Herkel J., Mittrucker H.W., Panzer U., Tiegs G. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis. J. Immunol. 2011, 186:5284-5293.
22. Eyers S., Weatherall M., Jefferies S., Beasley R. Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin. Exp. Allergy 2011, 41:482-489.
23. Farquhar H., Stewart A., Mitchell E., Crane J., Eyers S., Weatherall M., Beasley R. The role of paracetamol in the pathogenesis of asthma. Clin. Exp. Allergy 2010, 40:32-41.
24. Feldkamp M.L., Meyer R.E., Krikov S., Botto L.D. Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet. Gynecol. 2010, 115:109-115.
25. Flower R.J., Vane J.R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972, 240:410-411.
26. Fowden A.L., Forhead A.J., Coan P.M., Burton G.J. The placenta and intrauterine programming. J. Neuroendocrinol. 2008, 20:439-450.
27. Garcia-Marcos L., Sanchez-Solis M., Perez-Fernandez V., Pastor-Vivero M.D., Mondejar-Lopez P., Valverde-Molina J. Is the effect of prenatal paracetamol exposure on wheezing in preschool children modified by asthma in the mother?. Int. Arch. Allergy Immunol. 2009, 149:33-37.
28. Goksor E., Thengilsdottir H., Alm B., Norvenius G., Wennergren G. Prenatal paracetamol exposure and risk of wheeze at preschool age. Acta Paediatr. 2011, 100:1567-1571.
29. Graham G.G., Scott K.F. Mechanism of action of paracetamol. Am. J. Ther. 2005, 12:46-55.
30. Hahn R., Wendel A., Flohé L. The fate of extracellular glutathione in the rat. Biochim. Biophys. Acta 1978, 539:324-337.
31. Harrill A.H., Watkins P.B., Su S., Ross P.K., Harbourt D.E., Stylianou I.M., Boorman G.A., Russo M.W., Sackler R.S., Harris S.C., Smith P.C., Tennant R., Bogue M., Paigen K., Harris C., Contractor T., Wiltshire T., Rusyn I., Threadgill D.W. Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res. 2009, 19:1507-1515.
32. Heinonen O.P., Slone D., Monson R.R., Hook E.B., Shapiro S. Cardiovascular birth defects and antenatal exposure to female sex hormones. N. Engl. J. Med. 1977, 296:67-70.
33. Hinz B., Brune K. Paracetamol and cyclooxygenase inhibition: is there a cause for concern?. Ann. Rheum. Dis. 2012, 71:20-25.
34. Horowitz R.S., Dart R.C., Jarvie D.R., Bearer C.F., Gupta U. Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J. Toxicol. Clin. Toxicol. 1997, 35:447-451.
35. Imaeda A.B., Watanabe A., Sohail M.A., Mahmood S., Mohamadnejad M., Sutterwala F.S., Flavell R.A., Mehal W.Z. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 2009, 119:305-314.
36. Iqbal M., Audette M.C., Petropoulos S., Gibb W., Matthews S.G. Placental drug transporters and their role in fetal protection. Placenta 2012, 33:137-142.
37. Ishida Y., Kondo T., Ohshima T., Fujiwara H., Iwakura Y., Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 2002, 16:1227-1236.
38. Jaeschke H. Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol. 2005, 1:389-397.
39. Jaeschke H., Mcgill M.R., Williams C.D., Ramachandran A. Current issues with acetaminophen hepatotoxicity - a clinically relevant model to test the efficacy of natural products. Life Sci. 2011, 88:737-745.
40. Jaeschke H., Williams C.D., Ramachandran A., Bajt M.L. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int. 2012, 32:8-20.
41. Jick H. Effects of aspirin and acetaminophen in gastrointestinal hemorrhage. Results from the Boston Collaborative Drug Surveillance Program. Arch. Intern. Med. 1981, 141:316-321.
42. Jollow D.J., Mitchell J.R., Potter W.Z., Davis D.C., Gillette J.R., Brodie B.B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 1973, 187:195-202.
43. Ju C. Damage-associated molecular patterns: their impact on the liver and beyond during acetaminophen overdose. Hepatology 2012, 56(5):1599-1601.
44. Ju C., Reilly T.P., Bourdi M., Radonovich M.F., Brady J.N., George J.W., Pohl L.R. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem. Res. Toxicol. 2002, 15:1504-1513.
45. Kang E.M., Lundsberg L.S., Illuzzi J.L., Bracken M.B. Prenatal exposure to acetaminophen and asthma in children. Obstet. Gynecol. 2009, 114:1295-1306.
46. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 2005, 4:489-499.
47. Kessler T., Thiele K., Solano M.E., Arck P., Tiegs G., Erhardt A. Acetaminophen application during murine pregnancy triggers metabolic and immunological changes in dams and impairs fetal development. J. Reprod. Immunol. 2012, 94(1):20.
48. Kis B., Snipes J.A., Busija D.W. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J. Pharmacol. Exp. Ther. 2005, 315:1-7.
49. Koh K.H., Jurkovic S., Yang K., Choi S.Y., Jung J.W., Kim K.P., Zhang W., Jeong H. Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy. Biochem. Pharmacol. 2012, 84:93-103.
50. Kristensen D.M., Hass U., Lesne L., Lottrup G., Jacobsen P.R., Desdoits-Lethimonier C., Boberg J., Petersen J.H., Toppari J., Jensen T.K., Brunak S., Skakkebaek N.E., Nellemann C., Main K.M., Jegou B., Leffers H. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum. Reprod. 2011, 26:235-244.
51. Kurzel R.B. Can acetaminophen excess result in maternal and fetal toxicity?. South. Med. J. 1990, 83:953-955.
52. Larrey D., Letteron P., Foliot A., Descatoire V., Degott C., Geneve J., Tinel M., Pessayre D. Effects of pregnancy on the toxicity and metabolism of acetaminophen in mice. J. Pharmacol. Exp. Ther. 1986, 237:283-291.
53. Laub D.N., Elmagbari N.O., Elmagbari N.M., Hausburg M.A., Gardiner C.S. Effects of acetaminophen on preimplantation embryo glutathione concentration and development in vivo and in vitro. Toxicol. Sci. 2000, 56:150-155.
54. Lawson J.A., Fisher M.A., Simmons C.A., Farhood A., Jaeschke H. Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice. Toxicol. Appl. Pharmacol. 1999, 156:179-186.
55. Lee W.M. The case for limiting acetaminophen-related deaths: smaller doses and unbundling the opioid-acetaminophen compounds. Clin. Pharmacol. Ther. 2010, 88:289-292.
56. Lee Y.S., Kim H., Brahim J.S., Rowan J., Lee G., Dionne R.A. Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain 2007, 129:279-286.
57. Levy G., Khanna N.N., Soda D.M., Tsuzuki O., Stern L. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and d-glucaric acid excretion. Pediatrics 1975, 55:818-825.
58. Lewis R.M., Cleal J.K., Hanson M.A. Review: placenta, evolution and lifelong health. Placenta 2012, 33(Suppl.):S28-S32.
59. Li D.K., Liu L., Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. Br. Med. J. 2003, 327:368.
60. Liu Z.X., Govindarajan S., Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004, 127:1760-1774.
61. Liu Z.X., Kaplowitz N. Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol. 2006, 2:493-503.
62. Lubawy W.C., Garrett R.J. Effects of aspirin and acetaminophen on fetal and placental growth in rats. J. Pharm. Sci. 1977, 66:111-113.
63. Lum J.T., Wells P.G. Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophen. Teratology 1986, 33:53-72.
64. Lynberg M.C., Khoury M.J., Lu X., Cocian T. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am. J. Epidemiol. 1994, 140:244-255.
65. Marques P.E., Amaral S.S., Menezes G.B. Cell death products and neutrophil-mediated liver damage: beyond acetaminophen-induced injury. Hepatology 2012, (Epub ahead of print). 10.1002/hep.25884.
66. Masson M.J., Peterson R.A., Chung C.J., Graf M.L., Carpenter L.D., Ambroso J.L., Krull D.L., Sciarrotta J., Pohl L.R. Lymphocyte loss and immunosuppression following acetaminophen-induced hepatotoxicity in mice as a potential mechanism of tolerance. Chem. Res. Toxicol. 2007, 20:20-26.
67. McElhatton P.R., Sullivan F.M., Volans G.N. Paracetamol overdose in pregnancy analysis of the outcomes of 300 cases referred to the Teratology Information Service. Reprod. Toxicol. 1997, 11:85-94.
68. Mitra P., Audus K.L. MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells. Int. J. Pharm. 2010, 384:15-23.
69. Moffett A., Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006, 6:584-594.
70. Momma K., Takao A. Transplacental cardiovascular effects of four popular analgesics in rats. Am. J. Obstet. Gynecol. 1990, 162:1304-1310.
71. Momma K., Takeuchi H. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins 1983, 26:631-643.
72. Nelson M.M., Forfar J.O. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br. Med. J. 1971, 1:523-527.
73. O'brien W.F., Krammer J., O'leary T.D., Mastrogiannis D.S. The effect of acetaminophen on prostacyclin production in pregnant women. Am. J. Obstet. Gynecol. 1993, 168:1164-1169.
74. Park B.K., Kitteringham N.R., Maggs J.L., Pirmohamed M., Williams D.P. The role of metabolic activation in drug-induced hepatotoxicity. Annu. Rev. Pharmacol. Toxicol. 2005, 45:177-202.
75. Pastore L.M., Hertz-Picciotto I., Beaumont J.J. Risk of stillbirth from medications, illnesses and medical procedures. Paediatr. Perinat. Epidemiol. 1999, 13:421-430.
76. Patel R., Rosengren R.J. Acetaminophen elicits anti-estrogenic but not estrogenic responses in the immature mouse. Toxicol. Lett. 2001, 122:89-96.
77. Perzanowski M.S., Miller R.L., Tang D., Ali D., Garfinkel R.S., Chew G.L., Goldstein I.F., Perera F.P., Barr R.G. Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. Thorax 2010, 65:118-123.
78. Pincus M., Arck P. Developmental programming of allergic diseases. Chem. Immunol. Allergy 2012, 98:70-84.
79. Prescott L.F., Park J., Ballantyne A., Adriaenssens P., Proudfoot A.T. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 1977, 2:432-434.
80. Quiroga J., Prieto J. Liver cytoprotection by prostaglandins. Pharmacol. Ther. 1993, 58:67-91.
81. Rebordosa C., Kogevinas M., Bech B.H., Sorensen H.T., Olsen J. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. Int. J. Epidemiol. 2009, 38:706-714.
82. Rebordosa C., Kogevinas M., Horvath-Puho E., Norgard B., Morales M., Czeizel A.E., Vilstrup H., Sorensen H.T., Olsen J. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am. J. Obstet. Gynecol. 2008, 198(178):e1-e7.
83. Rebordosa C., Kogevinas M., Sorensen H.T., Olsen J. Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study. Int. J. Epidemiol. 2008, 37:583-590.
84. Rebordosa C., Zelop C.M., Kogevinas M., Sorensen H.T., Olsen J. Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort study. J. Matern. Fetal Neonatal Med. 2010, 23:371-378.
85. Reel J.R., Lawton A.D., Lamb J.C.T. Reproductive toxicity evaluation of acetaminophen in Swiss CD-1 mice using a continuous breeding protocol. Fundam. Appl. Toxicol. 1992, 18:233-239.
86. Reilly T.P., Brady J.N., Marchick M.R., Bourdi M., George J.W., Radonovich M.F., Pise-Masison C.A., Pohl L.R. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem. Res. Toxicol. 2001, 14:1620-1628.
87. Riggs B.S., Bronstein A.C., Kulig K., Archer P.G., Rumack B.H. Acute acetaminophen overdose during pregnancy. Obstet. Gynecol. 1989, 74:247-253.
88. Rumack C.M., Guggenheim M.A., Rumack B.H., Peterson R.G., Johnson M.L., Braithwaite W.R. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet. Gynecol. 1981, 58:52S-56S.
89. Schümann J., Wolf D., Pahl A., Brune K., Papadopoulos T., Van Rooijen N., Tiegs G. Importance of Kupffer cells for T cell-dependent liver injury in mice. Am. J. Pathol. 2000, 157:1671-1683.
90. 2O system for drug delivery system. J. Control. Release 2002, 81:367-377.
91. Shaheen S.O., Newson R.B., Henderson A.J., Headley J.E., Stratton F.D., Jones R.W., Strachan D.P. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin. Exp. Allergy 2005, 35:18-25.
92. Shaheen S.O., Newson R.B., Sherriff A., Henderson A.J., Heron J.E., Burney P.G., Golding J. Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002, 57:958-963.
93. Shaw G.M., Todoroff K., Velie E.M., Lammer E.J. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 1998, 57:1-7.
94. Solano M.E., Jago C., Pincus M.K., Arck P.C. Highway to health; or how prenatal factors determine disease risks in the later life of the offspring. J. Reprod. Immunol. 2011, 90:3-8.
95. Streissguth A.P., Treder R.P., Barr H.M., Shepard T.H., Bleyer W.A., Sampson P.D., Martin D.C. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology 1987, 35:211-219.
96. Su G.L., Gong K.Q., Fan M.H., Kelley W.M., Hsieh J., Sun J.M., Hemmila M.R., Arbabi S., Remick D.G., Wang S.C. Lipopolysaccharide-binding protein modulates acetaminophen-induced liver injury in mice. Hepatology 2005, 41:187-195.
97. Su G.L., Hoesel L.M., Bayliss J., Hemmila M.R., Wang S.C. Lipopolysaccharide binding protein inhibitory peptide protects against acetaminophen-induced hepatotoxicity. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G1319-G1325.
98. Thornton S.L., Minns A.B. Unintentional chronic acetaminophen poisoning during pregnancy resulting in liver transplantation. J. Med. Toxicol. 2012, 8:176-178.
99. Thulstrup A.M., Sorensen H.T., Nielsen G.L., Andersen L., Barrett D., Vilstrup H., Olsen J. Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy, EuroMap Study Group. Am. J. Perinatol. 1999, 16:321-326.
100. Tiegs G., Lohse A.W. Immune tolerance: what is unique about the liver. J. Autoimmun. 2010, 34:1-6.
101. Torfs C.P., Katz E.A., Bateson T.F., Lam P.K., Curry C.J. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 1996, 54:84-92.
102. Ueno K., Yamaura K., Nakamura T., Satoh T., Yano S. Acetaminophen-induced immunosuppression associated with hepatotoxicity in mice. Res. Commun. Mol. Pathol. Pharmacol. 2000, 108:237-251.
103. Vahakangas K., Myllynen P. Drug transporters in the human blood-placental barrier. Br. J. Pharmacol. 2009, 158:665-678.
104. Weigand U.W., Chou R.C., Maulik D., Levy G. Assessment of biotransformation during transfer of propoxyphene and acetaminophen across the isolated perfused human placenta. Pediatr. Pharmacol. (New York) 1984, 4:145-153.
105. Werler M.M., Louik C., Mitchell A.A. Epidemiologic analysis of maternal factors and amniotic band defects. Birth Defects Res. A: Clin. Mol. Teratol. 2003, 67:68-72.
106. Werler M.M., Mitchell A.A., Hernandez-Diaz S., Honein M.A. Use of over-the-counter medications during pregnancy. Am. J. Obstet. Gynecol. 2005, 193:771-777.
107. Werler M.M., Mitchell A.A., Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992, 45:361-367.
108. Werler M.M., Sheehan J.E., Mitchell A.A. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am. J. Epidemiol. 2002, 155:26-31.
109. Wilkes J.M., Clark L.E., Herrera J.L. Acetaminophen overdose in pregnancy. South. Med. J. 2005, 98:1118-1122.
110. Wright H.N. Chronic toxicity studies of analgesic and antipyretic drugs and congeners. Toxicol. Appl. Pharmacol. 1967, 11:280-292.
111. Yamaura K., Ogawa K., Yonekawa T., Nakamura T., Yano S., Ueno K. Inhibition of the antibody production by acetaminophen independent of liver injury in mice. Biol. Pharm. Bull. 2002, 25:201-205.
112. Yu M., Eckart M.R., Morgan A.A., Mukai K., Butte A.J., Tsai M., Galli S.J. Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. J. Clin. Invest. 2011, 121:3133-3143.
113. Zelop C.M. Is it time to re-evaluate our use of acetaminophen in certain sub-groups of pregnant women?. J. Matern. Fetal Neonatal Med. 2008, 21:761-762.
114. Zhang J., Huang W., Chua S.S., Wei P., Moore D.D. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 2002, 298:422-424.
115. Zierler S., Rothman K.J. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N. Engl. J. Med. 1985, 313:347-352.